LADENBURG THALMANN FINANCIAL SERVICES INC. - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 26 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$3,000
-93.5%
4,000
-82.6%
0.00%
Q2 2018$46,0000.0%23,0000.0%0.00%
Q1 2018$46,000
-22.0%
23,0000.0%0.00%
-100.0%
Q4 2017$59,000
+78.8%
23,0000.0%0.00%
Q3 2017$33,000
+6.5%
23,0000.0%0.00%
Q2 2017$31,00023,0000.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 4,859,885$11,955,0000.64%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$246,0000.00%
Alyeska Investment Group, L.P. 143,985$354,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 31,792$78,0000.00%
Geneva Advisors, LLC 12,500$31,0000.00%
BlackRock Investment Management, LLC 846$2,0000.00%
MORGAN STANLEY 500$1,0000.00%
BlackRock Institutional Trust Company, N.A. 28,379$70,0000.00%
Walleye Trading LLC 700$2,0000.00%
LPL Financial LLC 61,246$131,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders